Get involved

• For everybody
• For politicians
• For companies
• For foundations
• Make a donation
• Subcribe to our newsletter

1. TBVI »
2. Get involved »
3. For politicians

Tuberculosis is threatening societies all around the world: Europe, China, India, Africa, no continent is free of TB. The increase of drug resistant tuberculosis and co-infection with HIV make the problem even more urgent. With almost 2 million deaths and nearly 10 million new patients each year, tuberculosis is a huge cost to humanity and an enormous drain on the global economy. Yet promising vaccine research projects risk being put on hold because of lack of resources.

We need strong commitment from European and other governments and individual politicians to achieve our goal of elimination of TB. TuBerculosis Vaccine Initiative seeks to engage governments and politicians for political support, awareness building, innovative funding, guarantees and other advanced commitments. Taking into account the current difficult financial climate, TBVI has developed a new funding model that will allow promising discoveries to be translated into actual vaccines. For more information, please contact us.

Investing in vaccines will not only save lives, prevent health disaster and relieve poverty. It also contributes to building knowledge based economies, creating jobs and sustainable growth. Through our strategy, our working model and our projects, TBVI promotes international plans and policies such as the Lisbon Agenda, the Millennium Development Goals and the Stop TB Partnership.

TBVI commits to responsible use of all resources, effective solutions and long term positive social and economic impact.

What do we offer our partners?

• Access to our research results
• Possibilities for participation in Council of Trustees of TBVI, our prestigious network of globally renowned scientists, academic and political experts in health
• Working together on development of tools against elimination of TB
• Participation in our innovative way of funding, combining investment and charity
• Possibilities for tax incentives
• Cross sector cooperation – foundations, governments and private industries in a strong partnership to eliminate a major global health issue
• Pan-European approach – joint expertise of almost 40 worldwide research expert institutions

Social Impact

• With new vaccines save around 2 million lives a year and prevent suffering for millions of people
• Bring concrete solutions - TBVI's track record already shows high probability of success. Vaccines generally proved as promising and cost efficient
• Reduce poverty and stigmatization of people affected by tuberculosis
• Relieve communities affected by tuberculosis from the social and economic burdens caused by the disease
• Long term impact
• Healthy communities for people and businesses

Economic impact

• New vaccines will save hundreds of billions euro to the world economy, as the economic loss caused by tuberculosis now amounts to 0,52 per cent of the world’s gross national income
• Contribution to Europe's new knowledge based economy and technology
• Direct benefits to society: economic and social return on investment
• Cost efficiency: no investment wasted
• Knowledge and experience that is transferable worldwide 
• Leverage – elimination of tuberculosis will economically benefit families, communities, governments and companies.